Key result
G-CSF cuts cardiomyocyte apoptosis ~37% and reduces miR-34a expression in diabetic cardiomyopathy rats.
Why the study?
Although G-CSF was previously shown to attenuate cardiomyocyte apoptosis in diabetic cardiomyopathy, the regulatory role of cardiac miRNAs in this anti-apoptotic mechanism remained unknown.
Does granulocyte-colony stimulating factor reduce cardiomyocyte apoptosis through miRNA regulation in a diabetic cardiomyopathy model?
Does granulocyte-colony stimulating factor reduce cardiomyocyte apoptosis through miRNA regulation in a diabetic cardiomyopathy model?
G-CSF exerts anti-apoptotic effects in diabetic cardiomyopathy models, potentially by down-regulating miR-34a and up-regulating Bcl-2.
Answers are grounded in this paper and cite their sources.
G-CSF effects on apoptosis remain preclinical; hypothesis-generating for miR-34a-targeted therapies in diabetic cardiomyopathy.
Background: Recent studies have shown that microRNAs (miRNAs) are involved in the process of cardiomyocyte apoptosis.We have previously reported that granulocyte-colony stimulating factor (G-CSF) ameliorated diastolic dysfunction and attenuated cardiomyocyte apoptosis in a rat model of diabetic cardiomyopathy.In this study, we hypothesized a regulatory role of cardiac miRNAs in the mechanism of the anti-apoptotic effect of G-CSF in a diabetic cardiomyopathy rat model.Methods: Rats were given a high-fat diet and low-dose streptozotocin injection and then randomly allocated to receive treatment with either G-CSF or saline.H9c2 rat cardiomyocytes were cultured under a high glucose (HG) condition to induce diabetic cardiomyopathy in vitro.We examined the extent of apoptosis, miRNA expression, and miRNA target genes in the myocardium and H9c2 cells.Results: G-CSF treatment significantly decreased apoptosis and reduced miR-34a expression in diabetic myocardium and H9c2 cells under the HG condition.G-CSF treatment also significantly increased B-cell lymphoma 2 (Bcl-2) protein expression as a target for miR-34a.In addition, transfection with an miR-34a mimic significantly increased apoptosis and decreased Bcl-2 luciferase activity in H9c2 cells.Conclusion: Our results indicate that G-CSF might have an anti-apoptotic effect through down-regulation of miR-34a in a diabetic cardiomyopathy rat model.
No takes yet. Share an insight, caveat, or question.
Park et al. (2019) studied Diabetic cardiomyopathy (n=23). Granulocyte-colony stimulating factor (G-CSF) vs. Saline was evaluated on Cardiomyocyte apoptosis (TUNEL-positive cardiomyocytes) (p=<0.05). G-CSF treatment decreased cardiomyocyte apoptosis and reduced miR-34a expression in a rat model of diabetic cardiomyopathy compared to saline.
Synapse has enriched 10 related papers. Consider them for comparative context: